Statistics

Total Visits

Views
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort27

File Visits

Downloads
1935.pdf25

Select a period of time:

Number of views in the range

Views
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort18

Number of downloads in the range

Downloads
1935.pdf23

Views

Views
December 20250
January 20260
February 20260
March 20262
April 202610
May 20266
June 20260
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2025
    0
  • January 2026
    4
  • February 2026
    3
  • March 2026
    4
  • April 2026
    3
  • May 2026
    6
  • June 2026
    3
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Spain3
Antigua and Barbuda1
Angola1
Argentina1
Australia1
Colombia1
Ecuador1
Peru1
Turkey1
 

Top countries by downloads

Downloads
United States15
Angola1
Colombia1
 

Top cities views

Views
Bursa1
Charlotte1
Comodoro Rivadavia1
Huesca1
Lima1
Madrid1
Medellín1
Palma1
Portoviejo1
St John's1
 

Top cities by downloads

Downloads